Related Experiment Videos
[Collagen peptidase in Crohn's disease]
Deutsche Medizinische Wochenschrift (1946)
|April 30, 1976
Summary
Increased serum collagen-peptidase activity is a significant marker in Crohn's disease patients. Immunosuppressive drugs reduced this activity, suggesting a potential diagnostic role for collagen-peptidase in inflammatory bowel disease.
Area of Science:
- Biochemistry
- Gastroenterology
- Immunology
Context:
- Crohn's disease is a chronic inflammatory bowel disease.
- Serum collagen-peptidase activity is a potential biomarker.
- Elevated enzyme activity may indicate active inflammation.
Purpose:
- To investigate collagen-peptidase activity in Crohn's disease.
- To compare activity levels with control groups and sarcoidosis patients.
- To assess the effect of immunosuppressive therapy on enzyme levels.
Summary:
- Collagen-peptidase activity was elevated in 54 of 71 Crohn's disease cases (P < 0.001) compared to controls.
- Activity levels were higher than in sarcoidosis patients.
- Corticosteroids and azathioprine treatment reduced serum collagen-peptidase activity.
Impact:
- Suggests collagen-peptidase activity may serve as a diagnostic or monitoring tool for Crohn's disease.
- Highlights the enzyme's role in the inflammatory processes of Crohn's disease.
- Further research is needed to confirm diagnostic utility.